Observational Study on Mortality and Outcome of Patients Hospitalized for Subarachnoid Hemorrhage of Aneurysmal Origin in Martinique Between 2013 and 2021
HSA Rankin
1 other identifier
observational
122
1 country
1
Brief Summary
The aim of our study is to analyze mortality and sequelae of subarachnoid hemorrhage of aneurysmal origin in hospitalized patients in Martinique. Predictive factors of poor prognosis will also be analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 19, 2024
CompletedFirst Submitted
Initial submission to the registry
July 24, 2024
CompletedFirst Posted
Study publicly available on registry
July 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedMarch 31, 2025
March 1, 2025
6 months
July 24, 2024
March 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluate mortality in patients hospitalized for subarachnoid hemorrhage of aneurysmal origin over a 9-year period (2013-2021) in Martinique.
Mortality of subarachnoid hemorrhage of aneurysmal origin.
6 months
Secondary Outcomes (4)
Evaluate the clinical outcome of these patients.
6 months
Analyze the factors associated with a significant impairment of autonomy and/or dependence.
6 months
Analyze the factors associated with death.
6 months
Analyze the factors associated with a poor prognosis (death AND/OR significant impairment of autonomy/dependence).
6 months
Study Arms (1)
SAH of aneurysmal origin in hospitalized patients in Martinique between 2013 and 2021
Interventions
During hospitalization (2013-2021), patients were managed after multidisciplinary consultation in accordance with national recommendations between resuscitators, neurosurgeons and neuroradiologists, depending on the severity of the initial management and the patient's comorbidities, either by interventional radiology, neurosurgery or medical treatment.
Eligibility Criteria
Patients hospitalized in Martinique for subarachnoid hemorrhage of aneurysmal origin
You may qualify if:
- Adult (≥18 years) patients,
- Admitted to University Hospital of Martinique with subarachnoid hemorrhage of aneurysmal origin between 01/01/2013 and 31/12/2021,
- Informed patient/next-of-kin/treating physician consent for research participation.
You may not qualify if:
- Other causes of subarachnoid hemorrhage of non-aneurysmal origin (traumatic, arteriovenous malformation, cerebral tumor, cerebral thrombophlebitis).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Center of Martinique
Fort-de-France, 97261, Martinique
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2024
First Posted
July 29, 2024
Study Start
July 19, 2024
Primary Completion
December 31, 2024
Study Completion
April 1, 2025
Last Updated
March 31, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share